Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Схожие документы

• Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)
  по: Tam, Constantine S., et al.
  Опубликовано: (2014)
• Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia
  по: Badoux, Xavier C., et al.
  Опубликовано: (2011)
• Relevance of the immunoglobulin V(H) somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
  по: Lin, Katherine I., et al.
  Опубликовано: (2009)
• Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia
  по: Thompson, Philip A., et al.
  Опубликовано: (2016)
• Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
  по: Badoux, Xavier C., et al.
  Опубликовано: (2011)